Apheresis of activated leukocytes with an immobilized polymyxin B filter in patients with septic shock

Shock

Volumn 34, Issue 5, 2010, Pages 461-466

  Kumagai, Tuneyasu ^a   Takeyama, Naoshi ^b   Yabuki, Teru ^a   Harada, Makoto ^a   Miki, Yasuo ^a   Kanou, Hideki ^b   Inoue, Sousuke ^a   Nakagawa, Takashi ^a   Noguchi, Hiroshi ^b  

^a AICHI MEDICAL UNIVERSITY   (Japan)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CD11b; CD64; Chemokine receptors; endothelial damage; HLA DR; monocytes; neutrophil activation

Indexed keywords

CD11B ANTIGEN; CD64 ANTIGEN; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; POLYMYXIN B;

ADULT; AGED; APHERESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; CYTOKINE PRODUCTION; DRUG MECHANISM; ENDOTHELIUM CELL; ESCHERICHIA COLI; EX VIVO STUDY; FEMALE; FILTER; FLOW CYTOMETRY; HEMOPERFUSION; HUMAN; LEUKAPHERESIS; LEUKOCYTE ACTIVATION; LEUKOCYTE COUNT; LEUKOCYTE FUNCTION; LYMPHOCYTE; MALE; MONOCYTE; NEUTROPHIL; NEUTROPHIL COUNT; PHAGOCYTOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SEPSIS; SEPTIC SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THERAPY EFFECT;

ACUTE LUNG INJURY; AGED; ANTIGENS, SURFACE; CELLS, CULTURED; CYTOKINES; ENDOTHELIAL CELLS; ESCHERICHIA COLI; FEMALE; FILTRATION; FLOW CYTOMETRY; HEMOPERFUSION; HMGB1 PROTEIN; HUMANS; LEUKAPHERESIS; LEUKOCYTE COUNT; LEUKOCYTES; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; NEUTROPHILS; OPSONIN PROTEINS; PHAGOCYTOSIS; POLYMYXIN B; SHOCK, SEPTIC;

EID: 78149280955     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181e14ca0     Document Type: Article

References (32)

1. Tsuzuki H, Tani T, Ueyama H, Kodama M: Lipopolysaccharide: neutralization by polymyxin B shuts down the signaling pathway of nuclear factor. B in peripheral blood mononuclear cells, even during activation. J Surg Res 100:127-134, 2001.
2. Cruz DN, Antonelli M, Fumagalli R, Foltran F, Brienza N, Donati A, Malcangi V, Petrini F, Volta G, Pallavicini F M B, et al.: Early use of polymyxin B hemoperfusion in abdominal septic shock. JAMA 301:2445-2452, 2009.
3. Kushi H, Nakamura J, Miki T, Okamoto K, Saito T, Tanjo K: Hemoperfusion with an immobilized polymyxin B fiber column inhibits activation of vascular endothelial cells. Ther Apher Dial 9:303-307, 2005.
4. Tsushima K, Kubo K, Koizumi T, Yamamoto H, Fujimoto K, Hora K, Kan-Nou Y: Direct hemoperfusion using a polymyxin B immobilized column improves acute respiratory distress syndrome. J Clin Apher 17:97-102, 2002.
5. Kushi H, Miki T, Okamoto K, Nakahara J, Saito T, Tanjoh K: Early hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation. Crit Care 9: R653-R661, 2005.
6. Tsushima K, Kubo K, Yoshikawa S, Koizumi T, Yasuo M, Furuya S, Hora K: Effects of PMX-DHP treatment for patients with directly induced acute respiratory distress syndrome. Ther Apher Dial 11:138-145, 2007.
7. Dinarello CA: Proinflammatory cytokines. Chest 118:503-508, 2000.
8. Brown KA, Brain SD, Pearson JD, Edgeworth JD, Lewis SM, Treacher DF: Neutrophils in development of multiple organ failure in sepsis. Lancet 368:157-169, 2006.
9. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G: 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med 31:1250-1256, 2003.
10. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644-1655, 1992.
11. Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: a severity of disease classification system. Crit Care Med 13:818-829, 1985.
12. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG: The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707-710, 1996.
13. Lotz S, Aga E, Wilde I, van Zandberqen G, Hartung T, Solbach W, Laskay T: Highly purified lipoteichoic acid activates neutrophil granulocytes and delays their spontaneous apoptosis via CD14 and TLR2. J Leukoc Biol 75:467-477, 2004.
14. Toffoli MC, Gabra BH, Teixeira C F P, Sirois P, Jancar S: Endothelins mediate neutrophil activation, proMMP-9 release and endothelial cell detachment. Inflammation 30:28-37, 2007.
15. Ishiyama M, Miyazono Y, Sasamoto K, Ohkura Y, Ueno K: A highly watersoluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability. Talanta 44:1299-1305, 1997.
16. Cummings CJ, Martin TR, Frevert CW, Quan JM, Wong VA, Mongovin SM, Hagan TR, Steinberg KP, Goodman RB: Expression and function of the chemokine receptors CXCR1 and CXCR2 in sepsis. J Immunol 162:2341-2346, 1999.
17. Tarlowe MH, Duffy A, Kannan KB, Itagaki K, Lavery RF, Livingston DH, Bankey P, Hauser CJ: Prospective study of neutrophil chemokine responses in trauma patients at risk for pneumonia. Am J Respir Crit Care Med 171:753-759, 2005.
18. Gessler P, Pretre R, Hohl V, Rousson V, Fischer J, Dahinden C: CXC-chemokine stimulation of neutrophils correlates with plasma levels of myeloperoxidase and lactoferrin and contributes to clinical outcome after pediatric cardiac surgery. Shock 22:513-520, 2004.
19. Allen E, Bakke AC, Purtzer MZ, Deodhar A: Neutrophil CD64 expression: distinguishing acute inflammatory autoimmune disease from systemic infections. Ann Rheum Dis 61:522-525, 2002.
20. Ruiz P, Gomez F, Lopez R, Chien P, Rossman MD, Schreiber AD: Granulocyte Fc gamma receptor recognition of cell bound and aggregated IgG: effect of gamma-interferon. Am J Hematol 39:257-263, 1992.
21. Wakefield CH, Carey PD, Foulds S, Monson JR, Guillou PJ: Changes in major histocompatibility complex class II expression on monocytes and T-cells of patients developing infection after surgery. Br J Surg 80:205-209, 1993.
22. Ono S, Tsujimoto H, Matsumoto A, Ikuta S, Kinoshita M, Mochizuki H: Modulation of human leukocyte antigen-DR on monocytes and CD16 on granulocytes in patients with septic shock using hemoperfusion with polymyxin B-immobilized fiber. Am J Surg 188:150-156, 2004.
23. Nishibori M: Polymyxin-B column can attach the selected monocytes. Jpn J Crit Care Endotoxemia 8:90, 2004.
24. Fiore GB, Soncini M, Vesentini S, Penati A, Visconti G, Redaelli A: Multiscale analysis of the Toraymyxin absorption cartridge. Part II: computational fluid-dynamic study. Int J Artif Organs 29:251-260, 2006.
25. Vesentini S, Soncini M, Zaupa A, Silvestri V, Fiore GB, Redaelli A: Multiscale analysis of the Toraymyxin absorption cartridge. Part I: molecular interaction of polymyxin B with endotoxins. Int J Artif Organs 29:239-250, 2006.
26. Seely A J E, Pascual JL, Christou NV: Cell membrane expression (connectivity) regulates neutrophil delivery, function and clearance. Crit Care 7:291-307, 2003.
27. Suvorova ES, Gripentrog JM, Oppermann M, Miettinen HM: Role of the carboxyl terminal di-leucine in phosphorylation and internalization of C5a receptor. Biochem Biophys Acta 1783:1261-1270, 2008.
28. Brown KA, Lewis SW, Hill TA, Macey MG, McCarthey DA, Treacher DF: Leucodepletion and the interaction of polymorphonuclear cells with endothelium in systemic inflammatory response syndrome. Perfusion 16:75-83, 2001.
29. Vedder NB, Winn RK, Rice CL, Chi EY, Arfors KE, Harlan JM: A monoclonal antibody to the adherence-promoting leukocyte glycoprotein, CD18, reduces organ injury and resuscitation in rabbits. J Clin Invest 81:939-944, 1988.
30. Eichacker PQ, Hoffman WD, Farese A, Danner RL, Suffredini AF, Waisman Y, Banks SM, Mouginis T, Wilson L, Rothlein R, et al.: Leukocyte CD18 monoclonal antibody worsens endotoxemia and cardiovascular injury in canines with septic shock. J Appl Physiol 74:1885-1892, 1993.
31. Alexiou C, Tang A A T, Sheppard SV, Smith DC, Gibbs R, Liversey SA, Monro JL, Haw MP: The effect of leucodepletion on leukocyte activation, pulmonary inflammation and respiratory index in surgery for coronary revascularization: a prospective randomized study. Eur J Cardiothorac Surg 26:294-300, 2004.
32. Chen YF, Tsai WC, Lin CC, Tsai LY, Lee CS, Huang CH, Pan PC, Chen ML: Effect of leukocyte depletion on endothelial cell activation and transendothelial migration of leukocytes during cardiopulmonary bypass. Ann Thorac Surg 78:634-643, 2004.